Cargando…

Outcomes of children born to mothers with systemic lupus erythematosus exposed to hydroxychloroquine or azathioprine

OBJECTIVES: HCQ and AZA are used to control disease activity and reduce risk of flare during pregnancy in patients with SLE. The aim of this study was to determine the outcomes of children born to mothers with SLE exposed to HCQ or AZA during pregnancy and breast-feeding. METHODS: Women attending UK...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reynolds, John A, Gayed, Mary, Khamashta, Munther A, Leone, Francesca, Toescu, Veronica, Bruce, Ian N, Giles, Ian, Teh, Lee-Suan, McHugh, Neil, Akil, Mohammed, Edwards, Christopher J, Gordon, Caroline
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977116/ https://www.ncbi.nlm.nih.gov/pubmed/35766806 http://dx.doi.org/10.1093/rheumatology/keac372

Ejemplares similares

British isles lupus assessment group 2004 index is valid for assessment of disease activity in systemic lupus erythematosus
por: Yee, Chee-Seng, et al.
Publicado: (2007)

The use of Systemic Lupus Erythematosus Disease Activity Index-2000 to define active disease and minimal clinically meaningful change based on data from a large cohort of systemic lupus erythematosus patients
por: Yee, Chee-Seng, et al.
Publicado: (2011)

Neuropsychiatric Outcome of Children Born to Women With Systemic Lupus Erythematosus and Exposed in Utero to Azathioprine: A Case-Control Study
por: Lazzaroni, Maria-Grazia, et al.
Publicado: (2020)

Numerical scoring for the Classic BILAG index
por: Cresswell, Lynne, et al.
Publicado: (2009)

Flares in patients with systemic lupus erythematosus
por: McElhone, Kathleen, et al.
Publicado: (2020)

Azathioprine/etanercept: Systemic lupus erythematosus flare: case report
Publicado: (2021)

Azathioprine-Induced Pancreatitis in a Patient With Systemic Lupus Erythematosus
por: Ghazanfar, Haider, et al.
Publicado: (2022)

Sensitivity to Change and Minimal Important Differences of the LupusQoL in Patients With Systemic Lupus Erythematosus
por: McElhone, Kathleen, et al.
Publicado: (2016)

25-Hydroxyvitamin D deficiency is associated with increased aortic stiffness in patients with systemic lupus erythematosus
por: Reynolds, John A., et al.
Publicado: (2012)

Aseptic leptomeningitis induced by azathioprine in systemic lupus erythematosus: a rare manifestation
por: Santos, Mariana, et al.
Publicado: (2023)

The BILAG2004-Pregnancy Index is a valid disease activity outcome measure for pregnant SLE patients
por: Yee, Chee-Seng, et al.
Publicado: (2022)

Numerical scoring for the BILAG-2004 index
por: Yee, Chee-Seng, et al.
Publicado: (2010)

The BILAG-2004 systems tally—a novel way of representing the BILAG-2004 index scores longitudinally
por: Yee, Chee-Seng, et al.
Publicado: (2012)

The BILAG2004-Pregnancy index is reliable for assessment of disease activity in pregnant SLE patients
por: Yee, Chee-Seng, et al.
Publicado: (2012)

The BILAG-2004 index is sensitive to change for assessment of SLE disease activity
por: Yee, Chee-Seng, et al.
Publicado: (2009)

Hydroxychloroquine ototoxicity in a patient with systemic lupus erythematosus
por: Fernandes, Mariana Rita de Novaes, et al.
Publicado: (2018)

Hydroxychloroquine-induced retinal toxicity in systemic lupus erythematosus
por: Piggott, Kisha D, et al.
Publicado: (2018)

Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge
por: Dima, Alina, et al.
Publicado: (2022)

Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register
por: McCarthy, Eoghan M, et al.
Publicado: (2018)

Suppression of inflammation reduces endothelial microparticles in active systemic lupus erythematosus
por: Parker, Ben, et al.
Publicado: (2014)

Anifrolumab, an Anti–Interferon‐α Receptor Monoclonal Antibody, in Moderate‐to‐Severe Systemic Lupus Erythematosus
por: Furie, Richard, et al.
Publicado: (2017)

Azathioprine/hydroxychloroquine/prednisone: COVID-19: 2 case reports
Publicado: (2021)

Multichannel perimetric alterations in systemic lupus erythematosus treated with hydroxychloroquine
por: Piñero, David P., et al.
Publicado: (2017)

Outcomes of Systemic Lupus Erythematosus in Patients who Discontinue Hydroxychloroquine
por: Aouhab, Z., et al.
Publicado: (2019)

Hydroxychloroquine daily dose, hydroxychloroquine blood levels and the risk of flares in patients with systemic lupus erythematosus
por: Fasano, Serena, et al.
Publicado: (2023)

Anifrolumab effects on rash and arthritis: impact of the type I interferon gene signature in the phase IIb MUSE study in patients with systemic lupus erythematosus
por: Merrill, Joan T, et al.
Publicado: (2018)

Systemic Lupus Erythematosus-associated Acute Acalculous Cholecystitis Successfully Treated by a Corticosteroid Combined with Azathioprine
por: Kudo, Noritaka, et al.
Publicado: (2019)

Proteomic analysis identifies subgroups of patients with active systemic lupus erythematosus
por: Su, Kevin Y. C., et al.
Publicado: (2023)

Clinical and Immunologic Profiles in Incomplete Lupus Erythematosus and Improvement with Hydroxychloroquine Treatment
por: Olsen, Nancy J., et al.
Publicado: (2016)

Protective Effects of Hydroxychloroquine against Accelerated Atherosclerosis in Systemic Lupus Erythematosus
por: Floris, Alberto, et al.
Publicado: (2018)

Systemic Lupus Erythematosus: Perinatal Outcomes in Patients Treated With and Without Hydroxychloroquine
por: Baalbaki, Sima, et al.
Publicado: (2020)

Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study
por: Khamashta, Munther, et al.
Publicado: (2016)

Improved monitoring of clinical response in Systemic Lupus Erythematosus by longitudinal trend in soluble vascular cell adhesion molecule-1
por: Lewis, Myles J., et al.
Publicado: (2016)

Successful treatment of massive ascites due to lupus peritonitis with hydroxychloroquine in old- onset lupus erythematosus
por: Hammami, Sonia, et al.
Publicado: (2014)

Alopecia Universalis Associated with Hyperthyroidism Treated with Azathioprine and Hydroxychloroquine: A Case Report
por: Paudel, Vikash, et al.
Publicado: (2021)

Extensive Discoid Lupus Erythematosus in a HIV patient Responding to Hydroxychloroquine Monotherapy
por: Bhagwat, Pradeep Vittal, et al.
Publicado: (2012)

Incidental retinal vascular occlusions on hydroxychloroquine screening in patients with systemic lupus erythematosus
por: Bajwa, Asima, et al.
Publicado: (2015)

Hydroxychloroquine-Induced Psoriasis-form Erythroderma in a Patient with Systemic Lupus Erythematosus
por: Wang, Wen-Ming, et al.
Publicado: (2018)

Evaluation of Hydroxychloroquine Blood Concentrations and Effects in Childhood-Onset Systemic Lupus Erythematosus
por: Zahr, Noël, et al.
Publicado: (2021)

Hydroxychloroquine treatment in European patients with lupus erythematosus: dosing, retinopathy screening and adherence
por: Osmani, Zgjim, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o6ho5mf7cq6k0c89d9gh0ak3u0